Catherine J Crowley, David Yanowitch, Miriam Baigorri, Kyung Hae Hwang, Kelly Nett Cordero, Alejandro Gonzalez, Mariane Goes, Diana Bohórquez, Nicholas Sierra, Socorro Grijalva Zavaleta, Erika S Levy
Impact of an International Training on Interventionists' Expertise in Cleft Palate Speech: Results From Oaxaca, Mexico
American journal of speech-language pathology
hepatitis e virus hev emerging zoonotic pathogen leading cause acute viral hepatitis worldwide high risk developing chronic infection immunocompromised patients however global epidemiology hev infection comprehensively assessed study aims map global prevalence identify risk factors hev infection performing systematic review metaanalysis systematic searching articles published medline embase web science cochrane google scholar databases till july 2019 conducted identify studies hev prevalence data pooled prevalence among different countries continents estimated hev igg seroprevalence subgroups compared risk factors hev infection evaluated using odd ratios identified 419 related studies comprised 1 519 872 individuals total 1 099 717 participants pooled 287 studies general population estimated global antihev igg seroprevalence 1247 95 ci 10421467 i2 100 notably use elisa kits different manufacturers substantial impact global estimation antihev igg seroprevalence pooled estimate antihev igm seroprevalence based 98 studies 147 95 ci 114185 i2 99 overall estimate hev viral rnapositive rate general population 020 95 ci 015025 i2 98 consumption raw meat p 0001 exposure soil p 0001 blood transfusion p 0138 travelling endemic areas p 0244 contacting dogs p 0416 living rural areas p 0349 receiving education less elementary school p 0001 identified risk factors antihev igg positivity globally approximately 939 million corresponding 1 8 individuals ever experienced hev infection 15110 million individuals recent ongoing hev infection study highlights substantial burden hev infection calls increasing routine screening preventive measures